What is Volta Labs?
Volta Labs is at the forefront of bioautomation, developing sophisticated solutions designed to optimize and accelerate the critical upstream processes involved in genomic sequencing. By addressing bottlenecks in these workflows, the company aims to enhance the efficiency and throughput of genomic research and diagnostics. Their technology is poised to make a substantial impact on fields ranging from personalized medicine to drug discovery, enabling faster and more comprehensive genetic analysis.
How much funding has Volta Labs raised?
Volta Labs has raised a total of $20M across 1 funding round:
Series A
$20M
Series A (2022): $20M with participation from Casdin Capital, John Steulpnagel, Khosla Ventures, Maverick Ventures, E14 Fund, and Blindspot Ventures
Key Investors in Volta Labs
Casdin Capital
Casdin Capital is a venture capital firm specializing in life science innovation, with a strong track record in diagnostics and molecular information. They invest in pioneering companies, providing capital and strategic guidance to advance the field.
Khosla Ventures
Khosla Ventures is a prominent venture capital firm that supports entrepreneurs developing breakthrough technologies across various sectors, including AI, fintech, health, and sustainable energy.
Maverick Ventures
Maverick Ventures Israel is a venture capital firm dedicated to supporting technology start-ups by providing investment and operational support, focusing on diverse industries with exceptional teams and differentiated technology.
What's next for Volta Labs?
With the infusion of major strategic capital, Volta Labs is positioned for an accelerated phase of development and commercialization. The company is likely to focus on scaling its operations, expanding its research and development capabilities, and forging strategic partnerships within the genomics and biotechnology industries. This significant backing suggests investor confidence in Volta Labs' technology and its potential to revolutionize genomic sequencing workflows, paving the way for broader adoption and impact in scientific and clinical applications.
See full Volta Labs company page
